- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was keep. Nomination withdrawn. Ajpolino ( talk) 18:44, 13 October 2021 (UTC) Ajpolino ( talk) 18:44, 13 October 2021 (UTC)
Michelle McMurry-Heath
[Hide this box] New to Articles for deletion (AfD)? Read these primers!
- Michelle McMurry-Heath ( | talk | history | protect | delete | links | watch | logs | views) – ( View log)
- (Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
executive of an organizartion also nominated for deletion, at Wikipedia:Articles for deletion/Biotechnology Innovation Organization there is certainly no justifcation for two articles; this is a typical PR technique, and good evidence that neither is actually notable DGG ( talk ) 09:55, 9 October 2021 (UTC)
- Note: This discussion has been included in the list of Women-related deletion discussions. Spiderone (Talk to Spider) 11:20, 9 October 2021 (UTC)
- Note: This discussion has been included in the list of Medicine-related deletion discussions. Spiderone (Talk to Spider) 11:20, 9 October 2021 (UTC)
- Keep She is the subject of in-depth coverage focused on her in The Wall Street Journal, The Advice That Gave a Biotech Exec a Shot in the Arm (2020), and STATNews Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk? (2020), coverage in BloombergLaw (2020), as well as recent coverage in STATNews, BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights (2021, "Everyone wants to know whether Michelle McMurry-Heath, the newly minted president of the Biotechnology Innovation Organization, will be President Biden’s pick to lead the Food and Drug Administration. And whether, quite frankly, she wants the job."), the NYT, a brief mention in Biden closes in on pick to lead Food and Drug Administration (Politico, October 6, 2021), and she appears to have been featured as a public health expert, e.g. WTKR3, 2021. Beccaynr ( talk) 17:26, 9 October 2021 (UTC)
- I'm withdrawing the AfD request-- Beccaynr, I think you are correct. I was over-influenced by the corporate article connection. DGG ( talk ) 04:43, 12 October 2021 (UTC)
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was keep. Nomination withdrawn. Ajpolino ( talk) 18:44, 13 October 2021 (UTC) Ajpolino ( talk) 18:44, 13 October 2021 (UTC)
Michelle McMurry-Heath
[Hide this box] New to Articles for deletion (AfD)? Read these primers!
- Michelle McMurry-Heath ( | talk | history | protect | delete | links | watch | logs | views) – ( View log)
- (Find sources: Google ( books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
executive of an organizartion also nominated for deletion, at Wikipedia:Articles for deletion/Biotechnology Innovation Organization there is certainly no justifcation for two articles; this is a typical PR technique, and good evidence that neither is actually notable DGG ( talk ) 09:55, 9 October 2021 (UTC)
- Note: This discussion has been included in the list of Women-related deletion discussions. Spiderone (Talk to Spider) 11:20, 9 October 2021 (UTC)
- Note: This discussion has been included in the list of Medicine-related deletion discussions. Spiderone (Talk to Spider) 11:20, 9 October 2021 (UTC)
- Keep She is the subject of in-depth coverage focused on her in The Wall Street Journal, The Advice That Gave a Biotech Exec a Shot in the Arm (2020), and STATNews Biotech’s new chief lobbyist says she’s a social justice advocate. Will the industry walk the walk? (2020), coverage in BloombergLaw (2020), as well as recent coverage in STATNews, BIO’s chief on the FDA commissioner rumors, drug pricing, and IP rights (2021, "Everyone wants to know whether Michelle McMurry-Heath, the newly minted president of the Biotechnology Innovation Organization, will be President Biden’s pick to lead the Food and Drug Administration. And whether, quite frankly, she wants the job."), the NYT, a brief mention in Biden closes in on pick to lead Food and Drug Administration (Politico, October 6, 2021), and she appears to have been featured as a public health expert, e.g. WTKR3, 2021. Beccaynr ( talk) 17:26, 9 October 2021 (UTC)
- I'm withdrawing the AfD request-- Beccaynr, I think you are correct. I was over-influenced by the corporate article connection. DGG ( talk ) 04:43, 12 October 2021 (UTC)
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.